Search results
AbbVie's Upadacitinib Shows Clinical Response In Crohn's Disease Maintenance Study At One Year
Benzinga via Yahoo Finance· 2 years agoAbbVie Inc (NYSE: ABBV) announced topline results from U-ENDURE Phase 3 maintenance study evaluating...
AbbVie's (ABBV) Rinvoq Meets Crohn's Disease Study Goals
Zacks via Yahoo Finance· 2 years agoAbbVie's (ABBV) Rinvoq achieves statistical significance with its co-primary endpoints of clinical...
AbbVie's (ABBV) Rinvoq Meets Key Goal in Phase II Vitiligo Study
Zacks via Yahoo Finance· 7 months agoAbbVie ABBV announced positive results from its mid-stage study evaluating Rinvoq (upadacitinib) in...
AbbVie (ABBV) Outperforms Industry This Year So Far: Here's Why
Zacks via Yahoo Finance· 2 years agoAbbVie (ABBV) has several new drugs with the potential to drive revenues once Humira loses U.S....
AbbVie (ABBV) Files NDA for Parkinson's Disease Candidate
Zacks via Yahoo Finance· 2 years agoAbbVie Inc. ABBV submitted a new drug application (“NDA”) for ABBV-951 (foscarbidopa/foslevodopa)...
AbbVie (ABBV) Provides Clinical Updates on Inflammatory Drugs
Zacks via Yahoo Finance· 1 year agoAbbVie ABBV announced multiple clinical updates pertaining to clinical studies evaluating its...
Here's How Much You'd Have If You Invested $1000 in AbbVie a Decade Ago
Zacks via Yahoo Finance· 5 months agoHow much a stock's price changes over time is important for most investors, since price performance...
AbbVie (ABBV) to Boost Immunology Pipeline With New Acquisition
Zacks via Yahoo Finance· 2 years agoAbbVie Inc. ABBV recently announced that it has acquired UK-based private biotech, DJS Antibodies...
Can AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales?
Zacks via Yahoo Finance· 2 years agoAbbVie's (ABBV) new drugs, Skyrizi and Rinvoq, are faring well, bolstered by approval in new...
AbbVie's (ABBV) Rinvoq Gets FDA Nod to Treat Crohn's Disease
Zacks via Yahoo Finance· 11 months agoAbbVie (ABBV) announces the seventh FDA approval of its JAK inhibitor, Rinvoq, for the treatment of...